
Jeffrey H. Murray
Examiner (ID: 2022, Phone: (571)272-9023 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1699, 1609 |
| Total Applications | 1761 |
| Issued Applications | 1272 |
| Pending Applications | 9 |
| Abandoned Applications | 485 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7733430
[patent_doc_number] => 20120015920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'HETEROBICYCLIC METALLOPROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/163457
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76889
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015920.pdf
[firstpage_image] =>[orig_patent_app_number] => 13163457
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/163457 | Heterobicyclic metalloprotease inhibitors | Jun 16, 2011 | Issued |
Array
(
[id] => 7586812
[patent_doc_number] => 20110281322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/162449
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 42784
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281322.pdf
[firstpage_image] =>[orig_patent_app_number] => 13162449
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/162449 | INHIBITORS OF BRUTON'S TYROSINE KINASE | Jun 15, 2011 | Abandoned |
Array
(
[id] => 7511493
[patent_doc_number] => 20110257203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/161238
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 42789
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257203.pdf
[firstpage_image] =>[orig_patent_app_number] => 13161238
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/161238 | Inhibitors of Bruton's tyrosine kinase | Jun 14, 2011 | Issued |
Array
(
[id] => 7733604
[patent_doc_number] => 20120015963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/157777
[patent_app_country] => US
[patent_app_date] => 2011-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25506
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015963.pdf
[firstpage_image] =>[orig_patent_app_number] => 13157777
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/157777 | Pyrazolo[3,4-d]pyrimidine compounds | Jun 9, 2011 | Issued |
Array
(
[id] => 7696122
[patent_doc_number] => 20110230468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'FUSED HETEROCYCLIC COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/150675
[patent_app_country] => US
[patent_app_date] => 2011-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31585
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230468.pdf
[firstpage_image] =>[orig_patent_app_number] => 13150675
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/150675 | FUSED HETEROCYCLIC COMPOUNDS AND USES THEREOF | May 31, 2011 | Abandoned |
Array
(
[id] => 8904866
[patent_doc_number] => 20130172369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'PROCESSES FOR THE PREPARATION OF DIPYRIDAMOLE'
[patent_app_type] => utility
[patent_app_number] => 13/700845
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5966
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700845
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700845 | Processes for the preparation of dipyridamole | May 30, 2011 | Issued |
Array
(
[id] => 11762969
[patent_doc_number] => 09371327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-21
[patent_title] => 'PDE1 inhibitor compounds'
[patent_app_type] => utility
[patent_app_number] => 13/701225
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17165
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701225
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701225 | PDE1 inhibitor compounds | May 30, 2011 | Issued |
Array
(
[id] => 11205113
[patent_doc_number] => 09434730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-06
[patent_title] => 'PDE1 inhibitor compounds'
[patent_app_type] => utility
[patent_app_number] => 13/701284
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17533
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701284
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701284 | PDE1 inhibitor compounds | May 30, 2011 | Issued |
Array
(
[id] => 9212641
[patent_doc_number] => 20140011818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'ENANTIOMERS OF FLUCONAZOLE ANALOGUES CONTAINING THIENO-[2,-3-D]PYRIMIDIN-4(3H)-ONE MOIETY AS ANTIFUNGAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/004869
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4905
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004869
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/004869 | Enantiomers of fluconazole analogues containing thieno-[2,-3-D]pyrimidin-4(3H)-one moiety as antifungal agents | May 30, 2011 | Issued |
Array
(
[id] => 8977385
[patent_doc_number] => 20130210815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'SUBSTITUTED IMIDAZOPYRAZINES'
[patent_app_type] => utility
[patent_app_number] => 13/700956
[patent_app_country] => US
[patent_app_date] => 2011-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38537
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700956
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700956 | Substituted imidazopyrazines | May 26, 2011 | Issued |
Array
(
[id] => 9239240
[patent_doc_number] => 08604032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Chemical compounds, compositions and methods for kinase modulation'
[patent_app_type] => utility
[patent_app_number] => 13/112611
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65947
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112611
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112611 | Chemical compounds, compositions and methods for kinase modulation | May 19, 2011 | Issued |
Array
(
[id] => 9922967
[patent_doc_number] => 08980929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 13/643121
[patent_app_country] => US
[patent_app_date] => 2011-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22319
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/643121 | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes | May 15, 2011 | Issued |
Array
(
[id] => 6049098
[patent_doc_number] => 20110207929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'Process for preparing aminocrotonylamino-substituted quinazoline derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/101195
[patent_app_country] => US
[patent_app_date] => 2011-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4827
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207929.pdf
[firstpage_image] =>[orig_patent_app_number] => 13101195
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/101195 | Process for preparing aminocrotonylamino-substituted quinazoline derivatives | May 4, 2011 | Issued |
Array
(
[id] => 7744393
[patent_doc_number] => 20120022043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/099179
[patent_app_country] => US
[patent_app_date] => 2011-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45206
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022043.pdf
[firstpage_image] =>[orig_patent_app_number] => 13099179
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/099179 | Pyrazolopyrimidine JAK inhibitor compounds and methods | May 1, 2011 | Issued |
Array
(
[id] => 8173790
[patent_doc_number] => 20120108596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'Aza-Bicyclic Amine N-Oxide Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligand Pro-Drugs'
[patent_app_type] => utility
[patent_app_number] => 13/097153
[patent_app_country] => US
[patent_app_date] => 2011-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11326
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108596.pdf
[firstpage_image] =>[orig_patent_app_number] => 13097153
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/097153 | Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs | Apr 28, 2011 | Issued |
Array
(
[id] => 6064963
[patent_doc_number] => 20110201808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'NOVEL COMPOUND HAVING AFFINITY TO AMYLOID'
[patent_app_type] => utility
[patent_app_number] => 13/096159
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17257
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201808.pdf
[firstpage_image] =>[orig_patent_app_number] => 13096159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/096159 | NOVEL COMPOUND HAVING AFFINITY TO AMYLOID | Apr 27, 2011 | Abandoned |
Array
(
[id] => 9227543
[patent_doc_number] => 08633210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Triazole compounds useful as protein kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/094183
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86691
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13094183
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/094183 | Triazole compounds useful as protein kinase inhibitors | Apr 25, 2011 | Issued |
Array
(
[id] => 6113417
[patent_doc_number] => 20110190292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'HETEROBICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/084622
[patent_app_country] => US
[patent_app_date] => 2011-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23143
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190292.pdf
[firstpage_image] =>[orig_patent_app_number] => 13084622
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/084622 | Heterobicyclic compounds useful as kinase inhibitors | Apr 11, 2011 | Issued |
Array
(
[id] => 6087909
[patent_doc_number] => 20110217300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'Quinazolinone Compounds and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/080785
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24477
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217300.pdf
[firstpage_image] =>[orig_patent_app_number] => 13080785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/080785 | Quinazolinone Compounds and Methods of Use Thereof | Apr 5, 2011 | Abandoned |
Array
(
[id] => 8056223
[patent_doc_number] => 20120077828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/069569
[patent_app_country] => US
[patent_app_date] => 2011-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85322
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077828.pdf
[firstpage_image] =>[orig_patent_app_number] => 13069569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/069569 | CHEMICAL COMPOUNDS | Mar 22, 2011 | Abandoned |